https://scholars.lib.ntu.edu.tw/handle/123456789/362986
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Lee, Chia-Hsien | en_US |
dc.contributor.author | Huang, Hsuan-Cheng | en_US |
dc.contributor.author | Juan, Hsueh-Fen | en_US |
dc.creator | Juan, Hsueh-Fen;Huang, Hsuan-Cheng;Lee, Chia-Hsien;HSUEH-FEN JUAN;HSUEH-FEN JUAN;Juan, Hsueh-Fen;Huang, Hsuan-Cheng;Lee, Chia-Hsien | - |
dc.date.accessioned | 2018-09-10T08:36:09Z | - |
dc.date.available | 2018-09-10T08:36:09Z | - |
dc.date.issued | 2011 | - |
dc.identifier.uri | http://europepmc.org/abstract/med/21954360 | - |
dc.identifier.uri | http://scholars.lib.ntu.edu.tw/handle/123456789/362986 | - |
dc.description.abstract | Following major advances in the field of medicinal chemistry, novel drugs can now be designed systematically, instead of relying on old trial and error approaches. Current drug design strategies can be classified as being either ligand- or structure-based depending on the design process. In this paper, by describing the search for an ATP synthase inhibitor, we review two frequently used approaches in ligand-based drug design: The pharmacophore model and the quantitative structure-activity relationship (QSAR) method. Moreover, since ATP synthase ligands are potentially useful drugs in cancer therapy, pharmacophore models were constructed to pave the way for novel inhibitor designs. ? 2011 by the authors; licensee MDPI, Basel, Switzerland. | - |
dc.language | en | en |
dc.publisher | MDPI | - |
dc.relation.ispartof | International Journal of Molecular Sciences | - |
dc.source | AH | - |
dc.subject | ATP synthase ligands; Pharmacophore; Quantitative structure-activity relationships | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | adenosine triphosphatase inhibitor; asteltoxin; aurovertin b; bathophenanthroline; citreoviridin; enterostatin; ligand; mepacrine mustard; piceatannol; proton transporting adenosine triphosphate synthase inhibitor; resveratrol; unclassified drug; enzyme inhibitor; protein binding; protein subunit; proton transporting adenosine triphosphate synthase; binding site; cancer therapy; computer aided design; drug design; drug protein binding; drug structure; hydrogen bond; intermethod comparison; ligand binding; molecular docking; pharmacophore; prediction; process optimization; quantitative structure activity relation; review; scoring system; surface property; three dimensional imaging; validation process; antagonists and inhibitors; chemical phenomena; chemical structure; chemistry; human; metabolism; protein subunit; Binding Sites; Drug Design; Enzyme Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Mitochondrial Proton-Translocating ATPases; Models, Molecular; Protein Binding; Protein Subunits; Quantitative Structure-Activity Relationship | - |
dc.title | Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor. | - |
dc.type | journal article | en |
dc.identifier.doi | 10.3390/ijms12085304 | - |
dc.relation.pages | 5304-5318 | - |
dc.relation.journalvolume | 12 | - |
dc.relation.journalissue | 8 | - |
item.fulltext | no fulltext | - |
item.cerifentitytype | Publications | - |
item.openairetype | journal article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.grantfulltext | none | - |
crisitem.author.dept | Molecular and Cellular Biology | - |
crisitem.author.dept | Life Science | - |
crisitem.author.dept | Genome and Systems Biology Degree Program | - |
crisitem.author.dept | Office of Research and Development | - |
crisitem.author.orcid | 0000-0003-4876-3309 | - |
crisitem.author.parentorg | College of Life Science | - |
crisitem.author.parentorg | College of Life Science | - |
crisitem.author.parentorg | College of Life Science | - |
crisitem.author.parentorg | Administrative Unit | - |
顯示於: | 生命科學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。